- Home
- DINO vs HALO Comparison
DINO vs HALO Comparison
Compare DINO & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DINO
- HALO
- Stock Information
- Founded
- DINO 1947
- HALO 1998
- Country
- DINO United States
- HALO United States
- Employees
- DINO N/A
- HALO N/A
- Industry
- DINO Oil & Gas Production
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- DINO Energy
- HALO Health Care
- Exchange
- DINO Nasdaq
- HALO Nasdaq
- Market Cap
- DINO 6.7B
- HALO 7.3B
- IPO Year
- DINO N/A
- HALO N/A
- Fundamental
- Price
- DINO $36.30
- HALO $57.75
- Analyst Decision
- DINO Buy
- HALO Buy
- Analyst Count
- DINO 10
- HALO 9
- Target Price
- DINO $49.78
- HALO $62.78
- AVG Volume (30 Days)
- DINO 2.9M
- HALO 1.1M
- Earning Date
- DINO 02-20-2025
- HALO 02-18-2025
- Dividend Yield
- DINO 5.44%
- HALO N/A
- EPS Growth
- DINO N/A
- HALO 63.33
- EPS
- DINO 0.91
- HALO 3.43
- Revenue
- DINO $28,580,000,000.00
- HALO $1,015,324,000.00
- Revenue This Year
- DINO N/A
- HALO $23.48
- Revenue Next Year
- DINO N/A
- HALO $18.16
- P/E Ratio
- DINO $40.32
- HALO $16.84
- Revenue Growth
- DINO N/A
- HALO 22.44
- 52 Week Low
- DINO $33.47
- HALO $37.73
- 52 Week High
- DINO $64.16
- HALO $65.53
- Technical
- Relative Strength Index (RSI)
- DINO 46.76
- HALO 62.93
- Support Level
- DINO $34.55
- HALO $56.07
- Resistance Level
- DINO $39.32
- HALO $60.67
- Average True Range (ATR)
- DINO 1.67
- HALO 1.43
- MACD
- DINO 0.01
- HALO -0.22
- Stochastic Oscillator
- DINO 36.69
- HALO 48.86
About DINO HF Sinclair Corporation
HF Sinclair is an integrated petroleum refiner that owns and operates seven refineries serving the Rockies, midcontinent, Southwest, and Pacific Northwest, with a total crude oil throughput capacity of 678,000 barrels per day. It can produce 380 million gallons of renewable diesel annually. It holds a marketing business with over 300 distributors and 1,500 wholesale branded sites across 30 states. It also owns and operates 4,400 miles of petroleum product pipelines and terminals principally in the southwestern United States.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with unmet medical needs, with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.